# Nonclinical Safety Evaluation of Drug or Biologic Combinations - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-drug-or-biologic-combinations/a7c3b200-9178-4944-81a0-27721e31a958

> FDA guidance document: Nonclinical Safety Evaluation of Drug or Biologic Combinations. Issue date: March 15, 2006. Get complete insights and analysis.

---

## Details

- Title: Nonclinical Safety Evaluation of Drug or Biologic Combinations
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2006-03-15
- Last Changed: 2019-02-09
- Docket Number: <a href="https://www.regulations.gov/docket/2005D-0004">2005D-0004</a>

## Related Documents

- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Recommended Approaches to Integration of Genetic Toxicology Study Results](https://www.globalkeysolutions.net/guidances/guidance-document/recommended-approaches-to-integration-of-genetic-toxicology-study-results/9df3bcde-34b4-434c-9610-221248544f22)
- [Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics](https://www.globalkeysolutions.net/guidances/guidance-document/prescription-drug-marketing-act-donation-of-prescription-drug-samples-to-free-clinics/703c91fa-8616-445a-8a1e-5ad08e94d3f4)